David Ralph

3.3k total citations · 1 hit paper
45 papers, 1.6k citations indexed

About

David Ralph is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, David Ralph has authored 45 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 18 papers in Cardiology and Cardiovascular Medicine and 6 papers in Surgery. Recurrent topics in David Ralph's work include Pulmonary Hypertension Research and Treatments (16 papers), Urologic and reproductive health conditions (5 papers) and Sexual function and dysfunction studies (4 papers). David Ralph is often cited by papers focused on Pulmonary Hypertension Research and Treatments (16 papers), Urologic and reproductive health conditions (5 papers) and Sexual function and dysfunction studies (4 papers). David Ralph collaborates with scholars based in United States, United Kingdom and Netherlands. David Ralph's co-authors include Edgar J. Caldwell, Park W. Willis, Warren R. Summer, Neil Ettinger, Gary G. Koch, Maria M. Jöbsis, William G. Williams, Linda Clayton, Nicholas S. Hill and Alan L. Hinderliter and has published in prestigious journals such as Journal of Clinical Investigation, Journal of the American College of Cardiology and Circulation Research.

In The Last Decade

David Ralph

43 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension

2002 611 citations Ronald J. Raymond, Alan L. Hinderliter et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Ralph United States	17	1.1k	821	230	214	143	45	1.6k
Carl‐Erik Dempfle Germany	23	450 0.4×	713 0.9×	273 1.2×	446 2.1×	212 1.5×	47	1.7k
Anna Palmisano Italy	26	338 0.3×	1.2k 1.5×	387 1.7×	274 1.3×	162 1.1×	125	2.5k
Jolene M. Kriett United States	22	846 0.8×	820 1.0×	431 1.9×	175 0.8×	128 0.9×	53	1.6k
Billie Fyfe United States	24	239 0.2×	517 0.6×	623 2.7×	307 1.4×	460 3.2×	84	2.2k
George L. Zorn United States	27	740 0.7×	1.0k 1.3×	1.0k 4.4×	636 3.0×	64 0.4×	98	2.3k
Jen‐Ping Chang Taiwan	22	452 0.4×	552 0.7×	527 2.3×	263 1.2×	107 0.7×	85	1.4k
Colin Clelland United Kingdom	26	876 0.8×	382 0.5×	705 3.1×	381 1.8×	153 1.1×	52	2.0k
Penny J. Hunt New Zealand	17	289 0.3×	954 1.2×	606 2.6×	160 0.7×	190 1.3×	42	2.1k
Ulrich Neudorf Germany	22	319 0.3×	385 0.5×	208 0.9×	388 1.8×	449 3.1×	75	1.4k
Hiroshi Matsuoka Japan	21	302 0.3×	492 0.6×	405 1.8×	122 0.6×	254 1.8×	172	1.7k

Countries citing papers authored by David Ralph

Since Specialization

Citations

This map shows the geographic impact of David Ralph's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Ralph with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Ralph more than expected).

Fields of papers citing papers by David Ralph

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Ralph. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Ralph. The network helps show where David Ralph may publish in the future.

Co-authorship network of co-authors of David Ralph

This figure shows the co-authorship network connecting the top 25 collaborators of David Ralph. A scholar is included among the top collaborators of David Ralph based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Ralph. David Ralph is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Leary, Peter J., Samuel G. Rayner, Kelley R. Branch, et al.. (2025). Effect of Famotidine on Outcomes in Pulmonary Arterial Hypertension. CHEST Journal. 168(1). 189–199.

Lee, Don, et al.. (2024). United Kingdom data collection of semen quality in transgender adolescent females seeking fertility preservation. Fertility and Sterility. 123(2). 313–321. 3 indexed citations

Chen, Delphine L., Michael S. Mulligan, Karen Ordovás, et al.. (2023). Establishing a balloon pulmonary angioplasty program for chronic thromboembolic pulmonary hypertension: A United States single-center experience. Respiratory Medicine. 211. 107215–107215. 2 indexed citations

Xia, Lu, David Ralph, Samuel G. Rayner, et al.. (2023). Metabolomic Signatures Associated With Pulmonary Arterial Hypertension Outcomes. Circulation Research. 132(3). 254–266. 28 indexed citations

Rayner, Samuel G., et al.. (2022). Thyroid-stimulating hormone and mortality in pulmonary arterial hypertension. BMJ Open Respiratory Research. 9(1). e001348–e001348. 5 indexed citations

Ralph, David, Ying Zheng, William A. Altemeier, et al.. (2022). Circulating markers of inflammation and angiogenesis and clinical outcomes across subtypes of pulmonary arterial hypertension. The Journal of Heart and Lung Transplantation. 42(2). 173–182. 17 indexed citations

Houston, Brian A., David A. Bluemke, Steven M. Kawut, et al.. (2021). Associations of Angiopoietins With Heart Failure Incidence and Severity. Journal of Cardiac Failure. 27(7). 786–795. 19 indexed citations

Burger, Charles D., Daniel Grinnan, David Ralph, et al.. (2020). A Survey-based Estimate of COVID-19 Incidence and Outcomes among Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension and Impact on the Process of Care. Annals of the American Thoracic Society. 17(12). 1576–1582. 39 indexed citations

Ralph, David, et al.. (2020). PLASMA METABOLITE PROFILES ARE ASSOCIATED WITH RIGHT VENTRICULAR DYSFUNCTION AND PROGNOSIS IN PULMONARY ARTERIAL HYPERTENSION. Journal of the American College of Cardiology. 75(11). 2082–2082. 1 indexed citations

10.

Houston, Brian A., David A. Bluemke, Todd M. Kolb, et al.. (2020). Angiopoietin Associations Across the Cardiovascular Disease Spectrum: The Mesa Angiogenesis Study. A4239–A4239. 1 indexed citations

11.

Leary, Peter J., Nancy S. Jenny, David A. Bluemke, et al.. (2019). Endothelin-1, cardiac morphology, and heart failure: the MESA angiogenesis study. The Journal of Heart and Lung Transplantation. 39(1). 45–52. 14 indexed citations

12.

Leary, Peter J., Richard A. Kronmal, David A. Bluemke, et al.. (2017). Histamine H2 Receptor Polymorphisms, Myocardial Transcripts, and Heart Failure (from the Multi-Ethnic Study of Atherosclerosis and Beta-Blocker Effect on Remodeling and Gene Expression Trial). The American Journal of Cardiology. 121(2). 256–261. 14 indexed citations

13.

Krieger, Eric V., et al.. (2017). A Tale of Two Hearts: Patients with Decompensated Right Heart Failure in the Intensive Care Unit. Annals of the American Thoracic Society. 14(6). 1025–1030. 4 indexed citations

14.

Leary, Peter J., Todd M. Kolb, Bradley A. Maron, et al.. (2017). What’s in a side effect? The association between pulmonary vasodilator adverse drug events and clinical outcomes in patients with pulmonary arterial hypertension. International Journal of Cardiology. 240. 386–391. 6 indexed citations

15.

Leary, Peter J., R. Graham Barr, David A. Bluemke, et al.. (2014). H2 Receptor Antagonists and Right Ventricular Morphology: The MESA Right Ventricle Study. Annals of the American Thoracic Society. 11(9). 1379–1386. 16 indexed citations

16.

Leary, Peter J., et al.. (2012). Three‐Dimensional Analysis of Right Ventricular Shape and Function in Pulmonary Hypertension. Pulmonary Circulation. 2(1). 34–40. 44 indexed citations

17.

Raymond, Ronald J., Alan L. Hinderliter, Park W. Willis, et al.. (2002). Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. Journal of the American College of Cardiology. 39(7). 1214–1219. 611 indexed citations breakdown →

18.

Hinderliter, Alan L., Park W. Willis, Walker Long, et al.. (1999). Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension. The American Journal of Cardiology. 84(4). 481–484. 123 indexed citations

19.

Veltri, Robert W., Michael Craig Miller, Gang Zhao, et al.. (1999). Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer. Urology. 53(1). 139–147. 142 indexed citations

20.

Vitiello, Michael V., Charles W. Wilkinson, G. R. Merriam, et al.. (1997). Successful 6-Month Endurance Training Does Not Alter Insulin-Like Growth Factor-I in Healthy Older Men and Women. The Journals of Gerontology Series A. 52A(3). M149–M154. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact